TrialBritish journal of haematology2023

Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.

Robert Stuver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.